Cargando…
Correction: Soluble AXL: A Possible Circulating Biomarker for Neurofibromatosis Type 1 Related Tumor Burden
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363568/ https://www.ncbi.nlm.nih.gov/pubmed/25781925 http://dx.doi.org/10.1371/journal.pone.0119975 |
Ejemplares similares
-
Soluble AXL: A Possible Circulating Biomarker for Neurofibromatosis Type 1 Related Tumor Burden
por: Johansson, Gunnar, et al.
Publicado: (2014) -
Correction to: An update on the CNS manifestations of neurofibromatosis type 2
por: Coy, Shannon, et al.
Publicado: (2019) -
Correction: Neurofibromatosis Type 1 and the “Elephant Man's” Disease: The Confusion Persists: An Ethnographic Study
por: Legendre, Claire-Marie, et al.
Publicado: (2011) -
Correction: Neurofibromatosis Type 1 and the “Elephant Man's” Disease: The Confusion Persists: An Ethnographic Study
por: Legendre, Claire-Marie, et al.
Publicado: (2011) -
Correction to: Management of spinal deformities and tibial pseudarthrosis in children with neurofibromatosis type 1 (NF-1)
por: Mladenov, Kiril V., et al.
Publicado: (2021)